the aid library

LIST OPTIONS

Filter

4152

Sort by:

Direction:

Download (838)

View PDF (2011)

Essentials For Emergencies

World Health Organization (2004) C_WHO

The purpose of this booklet is to assist WHO and other Public Health workers in the field when an emergency occurs. The booklet provides technical hints on how to carry out a rapid health assessment, how to facilitate coordination, how departments in WHO can assist, etc. Standard formats for re... more

Download (919)

View PDF (1786)

Haemorrhagic Fevers in Africa: Narratives, Politics and Path ways of Disease an Response

Melissa Leach STEPS Centre, Institute of Development Studies (2008) C1

Ebola

Download (218)

View PDF (229)

Psychoses

World Health Organization WHO (2015) C_WHO

PSY supporting material • Person stories • Case scenarios • Role plays • Multiple choice questions • Video links

Download (118)

View PDF (199)

ETHICAL GUIDELINES FOR BIOMEDICAL RESEARCH ON HUMAN PARTICIPANTS

Indian Council of Medical Research (ICMR) (2006) C1

Download (128)

View PDF (192)

ECOSOC Meeting “Addressing noncommunicable diseases and mental health: major challenges to sustainable development in the 21st century”

World Health Organization (2009) C_WHO

Discussion Paper "Mental health, poverty and development", July 2009

Download (862)

View PDF (951)

Philippine Practice Guidelines on the Diagnosis and Management of Diabetes Mellitus

UNITE FOR DIABETES PHILIPPINES (2010) C1

Download (248)

View PDF (301)

Indian Foods: AAPI's guide to nutrition, health and diabetes

Ranjita Misra Allied Publishers Private LTD. (2011) C2

2nd edition

Download (1104)

View PDF (2631)

Guide to Local Production: WHO-recommended Handrub Formulations
recommended

World Health Organization WHO (2010) C_WHO

This guide to local production of WHO-recommended handrub formulations is separated into two discrete but interrelated sections: Part A provides a practical guide for use at the pharmacy bench during the actual preparation of the formulation. Users may want to display the material on the wall of ... more

Download (406)

View PDF (327)

Situation Analysis of Disability Resources and Needs of Shantytowns near Lima, Peru

Hunt, J. Write State University Dayton (2011) C1

Master Publication

Download (2290)

View PDF (2426)

National Guidelines for Diagnosis and Treatment of Malaria

Ministry of Health and Social Welfare, The United Republic of Tanzania (2006) C1

Download (63)

View PDF (122)

Climate change and Human Health : risks and responses

World Health Organization (WHO) (2003) CC

Over the ages, human societies have altered local ecosystems and modified regional climates. Today the human influence has attained a global scale. This reflects the recent rapid increase in population size, energy consumption, intensity of land use, international trade and travel, and other human a... more

Download (51)

View PDF (204)

Taenia solium taeniosis/cysticercosis and the co-distribution with schistosomiasis in Africa

Braae, U.; Saarnak, C.; Mukaratirwa, S. et al. Parasites and Vectors (2015) CC

The major neglected tropical diseases, Taenia solium taeniosis/cysticercosis and schistosomiasis caused by Schistosoma mansoni or S. haematobium are presumed to be widely distributed in Africa. Taenia solium taeniosis/ cysticercosis has been reported as an emerging disease in different regions of Af... more

Download (66)

View PDF (98)

Environmental cleaning and infection prevention and control in health care facilities in low- and middle-income countries

World Health Organisation (WHO) (2023) C_WHO

Those who clean are the first line of defense against health care-associated infections (HAIs), and support efforts to reduce antimicrobial resistance (AMR). Strengthening the training of this important group can contribute to resolving many of today’s public health challenges. This is importan... more

Download (67)

View PDF (99)

Promoting the health of refugees and migrants: experiences from around the world

World Health Organization (WHO) (2023) C_WHO

This publication is a compendium of 49 country examples highlighting efforts in improving refugees’ and migrants’ health following the adoption of the WHO Global Action Plan on Promoting the health of refugees and migrants at the seventy-second World Health Assembly, in May 2019.

Download (127)

View PDF (108)

Assessing national capacity for the prevention and control of noncommunicable diseases: report of the 2021 global survey

World Health Organisation (WHO) (2023) C_WHO

To assess national-level responses to NCDs, WHO has implemented NCD country capacity surveys periodically since 2001. This report is the latest in that series. Since the first survey round, the NCD Country Capacity Survey (NCD CCS) has been conducted a further seven times, most recently in 2021. In ... more

Download (71)

View PDF (72)

Cholera in the WHO African Region: Weekly Regional Cholera Bulletin: 17 July 2023

World Health Organisation (WHO) (2023) C_WHO

The cholera outbreak has affected 14 countries in the WHO African Region. The climate-induced natural disasters such as cyclone and flooding in the southern African region and drought in the Horn of Africa led to increase in cases of cholera in many of the affected countries. With the rainy season c... more

Download (66)

View PDF (63)

AidData's Methodology for Tracking Underreported Financial Flows, Version 1.1.

Strange, A. M.; B. O’Donnell; D. Gamboa et al. AidData at William & Mary (2013) CC

AidData has developed a set of open source data collection methods to track project-level data on suppliers of official finance who do not participate in global reporting systems. This codebook outlines the version 1.1 set of TUFF procedures that have been developed, tested, refined, and implemented... more

Download (96)

View PDF (111)

Considerations for developing a national genomic surveillance strategy or action plan for pathogens with pandemic and epidemic potential

World Health Organization WHO (2023) C_WHO

Pathogen genomic surveillance has become a priority for public health systems in recent years. Genomic sequencing is increasingly being used to characterize pathogens and monitor important public health priorities (e.g. poliovirus, influenza virus, Mycobacterium tuberculosis and Vibrio cholerae, ant... more

Download (63)

View PDF (210)

Climate Risk Sourcebook

Deutsche Gesellschaft für Internationale Zusammenarbeit GIZ; Eurac Research; United Nations University (2023) CC

Climate change is one of the most urgent challenges for people and ecosystems worldwide. The recently published sixth Assessment Report (AR6) of the Intergovernmental Panel on Climate Change (IPCC) stresses the occurrence of widespread adverse impacts of climate change. Increased frequency and inten... more

Download (176)

View PDF (247)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Guide to Local Production: WHO-recommended Handrub Formulations recommended

Guide to Local Production: WHO-recommended Handrub Formulations
recommended